Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Deferasirox Fe3+ Chelate: Molecular Insights & Assay Strateg
2026-04-30
Explore the molecular pharmacology of Deferasirox Fe3+ chelate in iron overload treatment research. This article uniquely bridges mechanistic depth with practical assay guidance, providing advanced perspectives beyond standard protocols.
-
Laminin (925-933): Mechanistic Insights for Advanced Cell Mi
2026-04-30
Explore how Laminin (925-933) redefines cell migration and adhesion assays as a functional domain mimic of the laminin B1 chain. This article highlights its mechanistic distinctiveness, practical assay integration, and the translational impact for ECM and neurodegeneration research.
-
Lamotrigine in High-Throughput CNS and Cardiac Research Work
2026-04-29
Lamotrigine, as a dual sodium channel blocker and 5-HT inhibitor, empowers researchers to model epilepsy and cardiac arrhythmia with precision. Recent blood-brain barrier assay innovations further distinguish its value in CNS drug screening and translational workflows.
-
Gentamycin Sulfate in Bacterial Protein Synthesis Research
2026-04-29
Gentamycin Sulfate stands out as a gold-standard aminoglycoside antibiotic for dissecting bacterial protein synthesis and modeling resistance, particularly in Gram-negative systems. Leveraging new epidemiological and mechanistic insights, this article presents actionable protocols, troubleshooting advice, and workflow enhancements for advanced molecular microbiology.
-
Ciprofloxacin (SKU A8399): Evidence-Driven Solutions for Lab
2026-04-28
This article delivers scenario-driven guidance for leveraging Ciprofloxacin (SKU A8399) in cell viability, proliferation, and antimicrobial resistance research. Drawing on quantitative data and real-world lab challenges, it provides practical, literature-backed protocols and decision criteria for laboratory scientists seeking reproducibility and workflow confidence with Ciprofloxacin.
-
Novel PDK4 Inhibitors for Metabolic Disease: Mechanistic Adv
2026-04-28
This study introduces a new series of anthraquinone-derived allosteric PDK4 inhibitors, with compound 8c showing high potency and favorable pharmacokinetics. The findings provide a promising scaffold for metabolic disease drug development and highlight implications for glucose regulation, allergy, and cancer therapeutics.
-
Multilayered Regulation of TRIM46 in Neuronal Axon Formation
2026-04-27
This study uncovers how alternative splicing, nonsense-mediated decay, and protein stability interact to tightly control the temporal and neuron-specific expression of TRIM46 during axonogenesis. The findings illuminate a complex gene regulatory mechanism underlying neuronal polarization, advancing our understanding of axon specification.
-
RESTRICT-seq Reveals Epigenetic Dependencies in SCC Resistan
2026-04-27
The referenced study introduces RESTRICT-seq, a novel time-gated CRISPR screening platform, to dissect epigenetic mechanisms underlying squamous cell carcinoma (SCC) resistance. By uncovering critical histone acetyltransferase dependencies, the work advances precision epigenetics and provides a robust foundation for targeted inhibitor validation in cancer biology.
-
Cimetidine in Experimental Cancer & BBB Models: Advanced Pro
2026-04-26
Cimetidine’s unique partial agonist profile and solubility enable high-fidelity cancer and blood-brain barrier research, surpassing conventional H2 antagonists. This guide details optimized workflows, troubleshooting, and protocol enhancements with APExBIO’s high-purity offering.
-
Dlin-MC3-DMA: Ionizable Cationic Liposome for RNA Delivery
2026-04-25
D-Lin-MC3-DMA stands as the benchmark ionizable cationic liposome, enabling highly potent and safe delivery of siRNA and mRNA in advanced therapeutic research. This article translates recent machine learning-driven breakthroughs and hands-on workflow refinements into actionable guidance for maximizing hepatic gene silencing, vaccine, and immunotherapy applications.
-
Laminin (925-933): Enhancing Cell Migration and Adhesion Ass
2026-04-24
Laminin (925-933) from APExBIO empowers researchers with a defined, synthetic laminin B1 chain peptide to precisely dissect cell adhesion, migration, and receptor-mediated signaling in cancer and neurodegeneration studies. This article details protocol optimizations, troubleshooting insights, and bench-validated comparative advantages for reliable, translational basement membrane protein research.
-
Antibiotic Use and Resistance in Psychiatric Hospitals Durin
2026-04-24
This study provides a detailed retrospective analysis of antibacterial drug use and bacterial resistance patterns in a psychiatric hospital during the 2022 COVID-19 epidemic. The findings reveal that, despite lower antibiotic usage rates than regional and national levels, bacterial resistance remains a challenge, highlighting the importance of continuous monitoring and rational antibiotic stewardship in specialized mental health settings.
-
(-)-Norepinephrine (+)-bitartrate: Benchmarks in Adrenergic
2026-04-23
(-)-Norepinephrine (+)-bitartrate is a validated adrenergic receptor agonist with well-characterized activity, crucial for cardiovascular and metabolic pathway research. Its potency, storage parameters, and reproducibility make it a gold-standard agent for in vitro and animal model studies.
-
Mifepristone (RU486): Advanced Protocols for Cancer Research
2026-04-23
Mifepristone (RU486) from APExBIO is redefining cancer and reproductive biology workflows by enabling precision control of progesterone receptor signaling. This article delivers actionable experimental protocols, troubleshooting strategies, and translational insights, empowering researchers to leverage RU486 for oncology, fertility, and hormone-driven disease models.
-
Adipose-Neural Axis Drives Cardiac Arrhythmias via Leptin an
2026-04-22
Fan et al. (2024) demonstrate that the adipose-neural axis—mediated by leptin and neuropeptide Y (NPY)—is a key driver of epicardial adipose tissue (EAT)-related cardiac arrhythmias. Their stem cell-based coculture model reveals novel mechanistic targets, including the NPY/Y1 receptor pathway, with implications for arrhythmia intervention.